Search research articles
Contact Us
Filters
Showing results (751-760 of 886) with videos related to
Page
of 89
Sort By:
Oncotarget
|
June 23, 2014
RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells
Jung-Chen Su, Ping-Hui Tseng, Cheng-Yi Hsu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 5, 2022
EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway
Yachong Liu, Jia Song, Hongwei Zhang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 20, 2026
EGCG inactivates tumor necrosis factor-alpha (TNFα) by inducing its higher-order assembly
Huanhuan Xu, Chenqiang Du, Ying Chen, et al.
Journal of the American Geriatrics Society
|
July 24, 2019
Impact of Computer-Based and Pharmacist-Assisted Medication Review Initiated in the Emergency Department
Ying-Ling Liu, Li-Ling Chu, Hui-Chen Su, et al.
Scientific Reports
|
March 10, 2018
Comparative Proteomic Profiling and Biomarker Identification of Traditional Chinese Medicine-Based HIV/AIDS Syndromes
Li Wen, Ye-Fang Liu, Cen Jiang, et al.
Journal of Medicinal Chemistry
|
May 8, 2020
Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction
Yunyuan Huang, Yixiang Xu, Rongrong Song, et al.
Neoplasia (New York, N.Y.)
|
July 23, 2014
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma
Jung-Chen Su, Ping-Hui Tseng, Szu-Hsien Wu, et al.
Viruses
|
February 2, 2018
Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation
Yu-Min Lin, Hung-Yu Sun, Wen-Tai Chiu, et al.
Atherosclerosis
|
October 2, 2018
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
Martin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
JACC. Asia
|
April 8, 2026
Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment
Richard C O'Brien, Lourdes Ella Gonzalez-Santos, Brian Tomlinson, et al.
Page
of 89
Search research articles
Search
Showing results (751-760 of 886) with videos related to
Sort By:
Page
of 89
Oncotarget
|
June 23, 2014
RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells
Jung-Chen Su, Ping-Hui Tseng, Cheng-Yi Hsu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 5, 2022
EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway
Yachong Liu, Jia Song, Hongwei Zhang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 20, 2026
EGCG inactivates tumor necrosis factor-alpha (TNFα) by inducing its higher-order assembly
Huanhuan Xu, Chenqiang Du, Ying Chen, et al.
Journal of the American Geriatrics Society
|
July 24, 2019
Impact of Computer-Based and Pharmacist-Assisted Medication Review Initiated in the Emergency Department
Ying-Ling Liu, Li-Ling Chu, Hui-Chen Su, et al.
Scientific Reports
|
March 10, 2018
Comparative Proteomic Profiling and Biomarker Identification of Traditional Chinese Medicine-Based HIV/AIDS Syndromes
Li Wen, Ye-Fang Liu, Cen Jiang, et al.
Journal of Medicinal Chemistry
|
May 8, 2020
Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction
Yunyuan Huang, Yixiang Xu, Rongrong Song, et al.
Neoplasia (New York, N.Y.)
|
July 23, 2014
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma
Jung-Chen Su, Ping-Hui Tseng, Szu-Hsien Wu, et al.
Viruses
|
February 2, 2018
Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation
Yu-Min Lin, Hung-Yu Sun, Wen-Tai Chiu, et al.
Atherosclerosis
|
October 2, 2018
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
Martin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
JACC. Asia
|
April 8, 2026
Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment
Richard C O'Brien, Lourdes Ella Gonzalez-Santos, Brian Tomlinson, et al.
Page
of 89